Gelber, Richard D.
Dana-Farber Cancer Institute,
United States
2025 Rank: 28029
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1231 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28029 | 30981 |
| Total Cites | 77609 | 85146 |
| H-index | 118 | 124 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 1122 | 1199 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 9349 | 10121 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 54850 | 57554 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.48 |
| Self-Citation Percentage |
8.85%
|
|
Gelber, Richard D.
Harvard Medical School,
United States
2024 Rank: 25690
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1142 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25690 | 28538 |
| Total Cites | 77692 | 85490 |
| H-index | 116 | 122 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 1103 | 1178 |
| Number of Single+First+Last Authored Papers | 122 | 122 |
| Total Cites to Single+First+Last Authored Papers | 9029 | 9785 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 54474 | 57355 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.49 |
| Self-Citation Percentage |
9.12%
|
|
Gelber, Richard D.
Dana-Farber Cancer Institute,
United States
2022 Rank: 21923
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1002 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21923 | 24418 |
| Total Cites | 69592 | 77271 |
| H-index | 113 | 117 |
| Hm-index | 29 | 31 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 1047 | 1122 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 8346 | 9098 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 48447 | 51303 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.51 |
| Self-Citation Percentage |
9.94%
|
|
Gelber, Richard D.
Harvard Medical School,
United States
2020 Rank: 18646
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 924 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18646 | 20113 |
| Total Cites | 66104 | 73916 |
| H-index | 106 | 112 |
| Hm-index | 29 | 30 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 999 | 1074 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 8568 | 9377 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 44888 | 47654 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.55 |
| Self-Citation Percentage |
10.57%
|
|